Clinical Roundup Alligator Bioscience initiates phase I study of intratumoral mitazalimab in locally advanced pancreatic cancer May 17, 2024Vol.50 No.20
Clinical Roundup Kyowa Kirin forms global collaborative with advocacy groups to address unmet needs in cutaneous T-cell lymphoma May 17, 2024Vol.50 No.20
Clinical Roundup Merck discontinues arm of phase III trial evaluating vibostolimab + pembrolizumab in adjuvant high-risk melanoma May 17, 2024Vol.50 No.20
Clinical Roundup AI-based biomarker stratifies metastasis risk in patients with BCR post-prostatectomy May 10, 2024Vol.50 No.19
Clinical Roundup AI tool predicts success of focal therapy for prostate cancer May 10, 2024Vol.50 No.19
Clinical Roundup Poly-ICLC enhances dendritic cell vaccine for gliomas in phase II trial May 10, 2024Vol.50 No.19
Clinical Roundup Setanaxib combination improves PFS and OS in SCCHN in phase II trial May 10, 2024Vol.50 No.19
Clinical Roundup A nanoparticle can penetrate the blood-brain barrier and may help to treat brain metastases May 10, 2024Vol.50 No.19
Clinical Roundup Glucose-driven histone lactylation promotes immunosuppressive activity in glioblastoma May 10, 2024Vol.50 No.19
